Company: PAII-WT
Filing Date: 2025-07-08
Form Type: S-1/A
Source: 0001213900-25-062125
Chunk: 3

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-07-08
Form: S-1/A
Chunk 3
---
 under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. Item 15. Recent Sales of Unregistered Securities. On May 5, 2025, Pyrophyte Acquisition II LLC, our sponsor, paid $25,000, or approximately $0.003 per share, to cover certain of our offering costs in exchange for 7,255,952 Class B ordinary shares. In June 2025, our sponsor transferred 30,000 Class B ordinary shares to each of our independent director nominees (for an aggregate of 90,000 Class B ordinary shares) at the same per -shareprice at which our sponsor purchased such shares, or approximately $0.004 per share. Such securities were issued in connection with our organization

| II-1 |

| Part II |

pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 20,125,000 units if the underwriters’ over -allotmentoption is exercised in full and therefore that such founder shares would represent 26.5% of the outstanding shares after this offering. Up to 946,428 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised. Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our sponsor is to act as the company’s sponsor in connection with this offering. The limited liability company agreement of our sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated with our sponsor, or in connection with estate planning transfers. Our sponsor has committed to purchase an aggregate of 5,050,000 private placement warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $5,050,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. The private placement warrants will also be worthless if we do not complete our initial business combination. This purchase will take